Loading…

A simplified Bethesda system for reporting thyroid cytopathology using only four categories improves intra- and inter-observer diagnostic agreement and provides non-overlapping estimates of malignancy risks

Our previous study utilizing the 2008 NCI six‐category system (also known as The Bethesda System) for reporting thyroid fine‐needle aspirations (FNA) identified considerable overlap in diagnosis and in assigned malignancy risk estimates for the “follicular lesion of undetermined significance (FLUS)”...

Full description

Saved in:
Bibliographic Details
Published in:Diagnostic cytopathology 2012-05, Vol.40 (S1), p.E62-E68
Main Authors: Walts, Ann E., Bose, Shikha, Fan, Xuemo, Frishberg, David, Scharre, Karen, de Peralta-Venturina, Mariza, Zhai, Jing, Marchevsky, Alberto M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4257-26186dd6c5926c7ae8efd0099cace80817300ce3422d646b6dcf9e4ccf1000ed3
cites cdi_FETCH-LOGICAL-c4257-26186dd6c5926c7ae8efd0099cace80817300ce3422d646b6dcf9e4ccf1000ed3
container_end_page E68
container_issue S1
container_start_page E62
container_title Diagnostic cytopathology
container_volume 40
creator Walts, Ann E.
Bose, Shikha
Fan, Xuemo
Frishberg, David
Scharre, Karen
de Peralta-Venturina, Mariza
Zhai, Jing
Marchevsky, Alberto M.
description Our previous study utilizing the 2008 NCI six‐category system (also known as The Bethesda System) for reporting thyroid fine‐needle aspirations (FNA) identified considerable overlap in diagnosis and in assigned malignancy risk estimates for the “follicular lesion of undetermined significance (FLUS)” and “follicular neoplasm (FN)” categories and for the “suspicious for malignancy (Susp)” and “malignant” categories. We proposed a simplified Bethesda System for reporting thyroid FNAs that provided four non‐overlapping, statistically significant, and more clinically relevant diagnostic categories: unsatisfactory, benign, FLUS/FN, and Susp/malignant. In the current study, six cytopathologists participated in a blinded retrospective review of 60 thyroid FNAs and kappa statistics were utilized to compare the intra‐ and inter‐observer diagnostic agreements obtained using the six‐category and the simplified four‐category schemes. Surgical follow‐up was used to determine which scheme provided more discrete malignancy risk estimates. Use of the simplified four‐category scheme significantly improved intra‐ and inter‐observer diagnostic agreement levels, significantly increased the sensitivity of FNA for a diagnosis of carcinoma in the subsequently resected thyroid glands, and provided non‐overlapping malignancy risk estimates for each diagnostic category. Diagn. Cytopathol. 2012;40:E62–E68. © 2011 Wiley Periodicals, Inc.
doi_str_mv 10.1002/dc.21697
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1016672002</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1016672002</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4257-26186dd6c5926c7ae8efd0099cace80817300ce3422d646b6dcf9e4ccf1000ed3</originalsourceid><addsrcrecordid>eNp1kc9y1SAUhxlHx16rMz6Bw9INFfIHkmW9arVT60btkuHCSS42gQikmpf0mSTtbV254szwnY_D-SH0ktETRmnxxuiTgvFWPEIbRltBaFm2j9GmEXVNGC3bI_Qsxh-U0jZjT9FRwepa1GW1QX9OcbTjNNjOgsFvIe0hGoXjEhOMuPMBB5h8SNb1OO2X4K3Bekl-UmnvB98veI7rnXfDkvE5YK0S9D5YiDiLg79ZC5eCIlg5s5YQiN9FCDcQsLGqdz4mq7HqA8AILt1ya6c1udd5R7IkDGqa1pcgw2N-I2Lf4VENtnfK6QUHG6_jc_SkU0OEF4fzGH378P7r9iO5-HL2aXt6QXRV1IIUnDXcGK7rtuBaKGigM3k7rVYaGtowUVKqoayKwvCK77jRXQuV1l1eNwVTHqPXd9485s85jyRHGzUMg3Lg5ygZZZyLImfzD9XBxxigk1PIHwhLhuSanjRa3qaX0VcH67wbwTyA93FlgNwBv-wAy39F8t32XnjgbY7z9wOvwrXkohS1vLo8k5-vvgt2ec7lefkXa7e5CA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1016672002</pqid></control><display><type>article</type><title>A simplified Bethesda system for reporting thyroid cytopathology using only four categories improves intra- and inter-observer diagnostic agreement and provides non-overlapping estimates of malignancy risks</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Walts, Ann E. ; Bose, Shikha ; Fan, Xuemo ; Frishberg, David ; Scharre, Karen ; de Peralta-Venturina, Mariza ; Zhai, Jing ; Marchevsky, Alberto M.</creator><creatorcontrib>Walts, Ann E. ; Bose, Shikha ; Fan, Xuemo ; Frishberg, David ; Scharre, Karen ; de Peralta-Venturina, Mariza ; Zhai, Jing ; Marchevsky, Alberto M.</creatorcontrib><description>Our previous study utilizing the 2008 NCI six‐category system (also known as The Bethesda System) for reporting thyroid fine‐needle aspirations (FNA) identified considerable overlap in diagnosis and in assigned malignancy risk estimates for the “follicular lesion of undetermined significance (FLUS)” and “follicular neoplasm (FN)” categories and for the “suspicious for malignancy (Susp)” and “malignant” categories. We proposed a simplified Bethesda System for reporting thyroid FNAs that provided four non‐overlapping, statistically significant, and more clinically relevant diagnostic categories: unsatisfactory, benign, FLUS/FN, and Susp/malignant. In the current study, six cytopathologists participated in a blinded retrospective review of 60 thyroid FNAs and kappa statistics were utilized to compare the intra‐ and inter‐observer diagnostic agreements obtained using the six‐category and the simplified four‐category schemes. Surgical follow‐up was used to determine which scheme provided more discrete malignancy risk estimates. Use of the simplified four‐category scheme significantly improved intra‐ and inter‐observer diagnostic agreement levels, significantly increased the sensitivity of FNA for a diagnosis of carcinoma in the subsequently resected thyroid glands, and provided non‐overlapping malignancy risk estimates for each diagnostic category. Diagn. Cytopathol. 2012;40:E62–E68. © 2011 Wiley Periodicals, Inc.</description><identifier>ISSN: 8755-1039</identifier><identifier>EISSN: 1097-0339</identifier><identifier>DOI: 10.1002/dc.21697</identifier><identifier>PMID: 21557534</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Bethesda ; Biopsy, Fine-Needle - methods ; Biopsy, Fine-Needle - standards ; diagnostic agreement ; False Positive Reactions ; FNA ; Follow-Up Studies ; Humans ; kappa value ; National Cancer Institute (U.S.) ; Observer Variation ; Predictive Value of Tests ; Reproducibility of Results ; Retrospective Studies ; Risk Assessment ; Sensitivity and Specificity ; thyroid ; Thyroid Gland - pathology ; Thyroid Gland - surgery ; Thyroid Neoplasms - diagnosis ; Thyroid Neoplasms - pathology ; Thyroidectomy ; United States</subject><ispartof>Diagnostic cytopathology, 2012-05, Vol.40 (S1), p.E62-E68</ispartof><rights>Copyright © 2011 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4257-26186dd6c5926c7ae8efd0099cace80817300ce3422d646b6dcf9e4ccf1000ed3</citedby><cites>FETCH-LOGICAL-c4257-26186dd6c5926c7ae8efd0099cace80817300ce3422d646b6dcf9e4ccf1000ed3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21557534$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Walts, Ann E.</creatorcontrib><creatorcontrib>Bose, Shikha</creatorcontrib><creatorcontrib>Fan, Xuemo</creatorcontrib><creatorcontrib>Frishberg, David</creatorcontrib><creatorcontrib>Scharre, Karen</creatorcontrib><creatorcontrib>de Peralta-Venturina, Mariza</creatorcontrib><creatorcontrib>Zhai, Jing</creatorcontrib><creatorcontrib>Marchevsky, Alberto M.</creatorcontrib><title>A simplified Bethesda system for reporting thyroid cytopathology using only four categories improves intra- and inter-observer diagnostic agreement and provides non-overlapping estimates of malignancy risks</title><title>Diagnostic cytopathology</title><addtitle>Diagn. Cytopathol</addtitle><description>Our previous study utilizing the 2008 NCI six‐category system (also known as The Bethesda System) for reporting thyroid fine‐needle aspirations (FNA) identified considerable overlap in diagnosis and in assigned malignancy risk estimates for the “follicular lesion of undetermined significance (FLUS)” and “follicular neoplasm (FN)” categories and for the “suspicious for malignancy (Susp)” and “malignant” categories. We proposed a simplified Bethesda System for reporting thyroid FNAs that provided four non‐overlapping, statistically significant, and more clinically relevant diagnostic categories: unsatisfactory, benign, FLUS/FN, and Susp/malignant. In the current study, six cytopathologists participated in a blinded retrospective review of 60 thyroid FNAs and kappa statistics were utilized to compare the intra‐ and inter‐observer diagnostic agreements obtained using the six‐category and the simplified four‐category schemes. Surgical follow‐up was used to determine which scheme provided more discrete malignancy risk estimates. Use of the simplified four‐category scheme significantly improved intra‐ and inter‐observer diagnostic agreement levels, significantly increased the sensitivity of FNA for a diagnosis of carcinoma in the subsequently resected thyroid glands, and provided non‐overlapping malignancy risk estimates for each diagnostic category. Diagn. Cytopathol. 2012;40:E62–E68. © 2011 Wiley Periodicals, Inc.</description><subject>Bethesda</subject><subject>Biopsy, Fine-Needle - methods</subject><subject>Biopsy, Fine-Needle - standards</subject><subject>diagnostic agreement</subject><subject>False Positive Reactions</subject><subject>FNA</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>kappa value</subject><subject>National Cancer Institute (U.S.)</subject><subject>Observer Variation</subject><subject>Predictive Value of Tests</subject><subject>Reproducibility of Results</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>Sensitivity and Specificity</subject><subject>thyroid</subject><subject>Thyroid Gland - pathology</subject><subject>Thyroid Gland - surgery</subject><subject>Thyroid Neoplasms - diagnosis</subject><subject>Thyroid Neoplasms - pathology</subject><subject>Thyroidectomy</subject><subject>United States</subject><issn>8755-1039</issn><issn>1097-0339</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNp1kc9y1SAUhxlHx16rMz6Bw9INFfIHkmW9arVT60btkuHCSS42gQikmpf0mSTtbV254szwnY_D-SH0ktETRmnxxuiTgvFWPEIbRltBaFm2j9GmEXVNGC3bI_Qsxh-U0jZjT9FRwepa1GW1QX9OcbTjNNjOgsFvIe0hGoXjEhOMuPMBB5h8SNb1OO2X4K3Bekl-UmnvB98veI7rnXfDkvE5YK0S9D5YiDiLg79ZC5eCIlg5s5YQiN9FCDcQsLGqdz4mq7HqA8AILt1ya6c1udd5R7IkDGqa1pcgw2N-I2Lf4VENtnfK6QUHG6_jc_SkU0OEF4fzGH378P7r9iO5-HL2aXt6QXRV1IIUnDXcGK7rtuBaKGigM3k7rVYaGtowUVKqoayKwvCK77jRXQuV1l1eNwVTHqPXd9485s85jyRHGzUMg3Lg5ygZZZyLImfzD9XBxxigk1PIHwhLhuSanjRa3qaX0VcH67wbwTyA93FlgNwBv-wAy39F8t32XnjgbY7z9wOvwrXkohS1vLo8k5-vvgt2ec7lefkXa7e5CA</recordid><startdate>201205</startdate><enddate>201205</enddate><creator>Walts, Ann E.</creator><creator>Bose, Shikha</creator><creator>Fan, Xuemo</creator><creator>Frishberg, David</creator><creator>Scharre, Karen</creator><creator>de Peralta-Venturina, Mariza</creator><creator>Zhai, Jing</creator><creator>Marchevsky, Alberto M.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201205</creationdate><title>A simplified Bethesda system for reporting thyroid cytopathology using only four categories improves intra- and inter-observer diagnostic agreement and provides non-overlapping estimates of malignancy risks</title><author>Walts, Ann E. ; Bose, Shikha ; Fan, Xuemo ; Frishberg, David ; Scharre, Karen ; de Peralta-Venturina, Mariza ; Zhai, Jing ; Marchevsky, Alberto M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4257-26186dd6c5926c7ae8efd0099cace80817300ce3422d646b6dcf9e4ccf1000ed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Bethesda</topic><topic>Biopsy, Fine-Needle - methods</topic><topic>Biopsy, Fine-Needle - standards</topic><topic>diagnostic agreement</topic><topic>False Positive Reactions</topic><topic>FNA</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>kappa value</topic><topic>National Cancer Institute (U.S.)</topic><topic>Observer Variation</topic><topic>Predictive Value of Tests</topic><topic>Reproducibility of Results</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>Sensitivity and Specificity</topic><topic>thyroid</topic><topic>Thyroid Gland - pathology</topic><topic>Thyroid Gland - surgery</topic><topic>Thyroid Neoplasms - diagnosis</topic><topic>Thyroid Neoplasms - pathology</topic><topic>Thyroidectomy</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Walts, Ann E.</creatorcontrib><creatorcontrib>Bose, Shikha</creatorcontrib><creatorcontrib>Fan, Xuemo</creatorcontrib><creatorcontrib>Frishberg, David</creatorcontrib><creatorcontrib>Scharre, Karen</creatorcontrib><creatorcontrib>de Peralta-Venturina, Mariza</creatorcontrib><creatorcontrib>Zhai, Jing</creatorcontrib><creatorcontrib>Marchevsky, Alberto M.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diagnostic cytopathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Walts, Ann E.</au><au>Bose, Shikha</au><au>Fan, Xuemo</au><au>Frishberg, David</au><au>Scharre, Karen</au><au>de Peralta-Venturina, Mariza</au><au>Zhai, Jing</au><au>Marchevsky, Alberto M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A simplified Bethesda system for reporting thyroid cytopathology using only four categories improves intra- and inter-observer diagnostic agreement and provides non-overlapping estimates of malignancy risks</atitle><jtitle>Diagnostic cytopathology</jtitle><addtitle>Diagn. Cytopathol</addtitle><date>2012-05</date><risdate>2012</risdate><volume>40</volume><issue>S1</issue><spage>E62</spage><epage>E68</epage><pages>E62-E68</pages><issn>8755-1039</issn><eissn>1097-0339</eissn><abstract>Our previous study utilizing the 2008 NCI six‐category system (also known as The Bethesda System) for reporting thyroid fine‐needle aspirations (FNA) identified considerable overlap in diagnosis and in assigned malignancy risk estimates for the “follicular lesion of undetermined significance (FLUS)” and “follicular neoplasm (FN)” categories and for the “suspicious for malignancy (Susp)” and “malignant” categories. We proposed a simplified Bethesda System for reporting thyroid FNAs that provided four non‐overlapping, statistically significant, and more clinically relevant diagnostic categories: unsatisfactory, benign, FLUS/FN, and Susp/malignant. In the current study, six cytopathologists participated in a blinded retrospective review of 60 thyroid FNAs and kappa statistics were utilized to compare the intra‐ and inter‐observer diagnostic agreements obtained using the six‐category and the simplified four‐category schemes. Surgical follow‐up was used to determine which scheme provided more discrete malignancy risk estimates. Use of the simplified four‐category scheme significantly improved intra‐ and inter‐observer diagnostic agreement levels, significantly increased the sensitivity of FNA for a diagnosis of carcinoma in the subsequently resected thyroid glands, and provided non‐overlapping malignancy risk estimates for each diagnostic category. Diagn. Cytopathol. 2012;40:E62–E68. © 2011 Wiley Periodicals, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>21557534</pmid><doi>10.1002/dc.21697</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 8755-1039
ispartof Diagnostic cytopathology, 2012-05, Vol.40 (S1), p.E62-E68
issn 8755-1039
1097-0339
language eng
recordid cdi_proquest_miscellaneous_1016672002
source Wiley-Blackwell Read & Publish Collection
subjects Bethesda
Biopsy, Fine-Needle - methods
Biopsy, Fine-Needle - standards
diagnostic agreement
False Positive Reactions
FNA
Follow-Up Studies
Humans
kappa value
National Cancer Institute (U.S.)
Observer Variation
Predictive Value of Tests
Reproducibility of Results
Retrospective Studies
Risk Assessment
Sensitivity and Specificity
thyroid
Thyroid Gland - pathology
Thyroid Gland - surgery
Thyroid Neoplasms - diagnosis
Thyroid Neoplasms - pathology
Thyroidectomy
United States
title A simplified Bethesda system for reporting thyroid cytopathology using only four categories improves intra- and inter-observer diagnostic agreement and provides non-overlapping estimates of malignancy risks
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T05%3A57%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20simplified%20Bethesda%20system%20for%20reporting%20thyroid%20cytopathology%20using%20only%20four%20categories%20improves%20intra-%20and%20inter-observer%20diagnostic%20agreement%20and%20provides%20non-overlapping%20estimates%20of%20malignancy%20risks&rft.jtitle=Diagnostic%20cytopathology&rft.au=Walts,%20Ann%20E.&rft.date=2012-05&rft.volume=40&rft.issue=S1&rft.spage=E62&rft.epage=E68&rft.pages=E62-E68&rft.issn=8755-1039&rft.eissn=1097-0339&rft_id=info:doi/10.1002/dc.21697&rft_dat=%3Cproquest_cross%3E1016672002%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4257-26186dd6c5926c7ae8efd0099cace80817300ce3422d646b6dcf9e4ccf1000ed3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1016672002&rft_id=info:pmid/21557534&rfr_iscdi=true